- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 15, 2026 | 163.9M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 159.45M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 155.54M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 131.08M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 127.81M sh |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | −$200.9K |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | −$41.61K |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $1.84M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | −$3.12M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | −$2.69M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | −$2.44M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | −$1.82M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | −$1.56M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | −$1.26M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $1.43M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $1.12M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $2.94M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $2.51M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $96.38K |
| Current Assets | Q2 2026 · Sep 30, 2025 | $320.53K |
| Total Assets | Q2 2026 · Mar 31, 2026 | $159.82K |
| Total Assets | Q2 2026 · Sep 30, 2025 | $409.22K |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$0.01 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$0.01 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | −$0.02 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $114.39K |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $300.27K |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $95.47K |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $1.15M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$521.11K |
| Net Income | Q2 2026 · Mar 31, 2026 | −$1.04M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$521.64K |
| Net Income | Q2 2026 · Mar 31, 2025 | −$641.82K |
| Net Income | Q2 2026 · Mar 31, 2025 | −$1.98M |
| Net Income | Q2 2026 · Dec 31, 2024 | −$1.34M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$420.39K |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$895.41K |
| Operating Income | Q2 2026 · Mar 31, 2025 | −$669.16K |
| Operating Income | Q2 2026 · Mar 31, 2025 | −$1.97M |
| Capex | Q2 2026 · Mar 31, 2025 | $1.73K |